MMP9 and neoplasm: The coinjection of tumor cells with tumor-derived MDSCs enhances tumor angiogenesis, as MDSCs produce MMP9, which regulates the bioavailability of vascular endothelial growth factor (VEGF) and promotes angiogenesis (129).